This newslink doesn't exist or it was removed.
Go to Homempage.
WPTV USA Nation March 17, 2023
Amid pressure from both the public and the Biden administration, a third insulin maker announced it is capping insulin prices. The announcement this week by Sanofi means the three largest insulin producers in the world have instituted price caps in recent... + más
Sanofi Cuts Insulin Prices Up To 78%—Following Eli Lilly And Novo Nordisk | Forbes
Sanofi to cut U.S. insulin prices by up to 78%, capping cost at $35 | ABC7
Forbes USA Business March 17, 2023
Topline Pharmaceutical giant Sanofi announced Thursday it will cut the price of its most commonly prescribed insulin by 78% and cap the monthly cost at $35, becoming the latest drug maker—behind Eli Lilly and Novo Nordisk—to slash insulin costs this month, amid growing calls... + más
Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly | Forbes
How the Other Insulin Makers Are Responding to Eli Lilly’s Price Cap | Time
CNBC USA Health March 16, 2023
A pharmacist holds a box of the drug Lantus SoloStar, made by Sanofi Pharmaceutical, at a pharmacy in Provo, Utah, January 9, 2020.George Frey Reuters on Thursday said it's planning to cut the U.S. price of its most popular insulin drug by 78% and cap monthly out-of-pocket... + más
ABC News USA Health November 04, 2022
In what could signal the promise of progress to come for newborn infants at risk for RSV, a new monoclonal antibody is being granted approval in Europe as a preventative measure to protect against RSV infection in very young babies -- those most at risk of contracting the virus... + más
Pfizer says study shows vaccinating pregnant women protects newborns from RSV | ABC7
Strong RSV vaccine data lifts hopes after years of futility | 10 WBNS
ABC News USA Health August 04, 2023
A new immunization to protect infants from was approved by the Centers for Disease Control and Prevention on Thursday.The approved drug called nirsevimab, which will be marketed in the U.S. by Sanofi as Beyfortus, was recommended unanimously by the CDC's Advisory Committee... + más
RSV season may have already begun, CDC warns, with early activity in the Southeast | Los Angeles Times
First-ever RSV vaccine could be approved, roll out by August | New York Post
About iurex | Privacy Policy | Disclaimer |